Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2371 AL 2385

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan

Fouquet M, Besson FL, Gonneaud J, La Joie R, Chételat G.

Neuropsychol Rev. 2014 Sep;24(3):290-9. doi: 10.1007/s11065-014-9263-8. Epub 2014 Aug 22.

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L.

Alzheimers Dement. 2014 Nov;10(6):808-17. doi: 10.1016/j.jalz.2014.03.003. Epub 2014 Aug 20.

An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach

Cenini G, Fiorini A, Sultana R, Perluigi M, Cai J, Klein JB, Head E, Butterfield DA.

Free Radic Biol Med. 2014 Nov;76:89-95. doi: 10.1016/j.freeradbiomed.2014.08.006. Epub 2014 Aug 20.

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Babić M, Svob Štrac D, Mück-Šeler D, Pivac N, Stanić G, Hof PR, Simić G.

Croat Med J. 2014 Aug 28;55(4):347-65. doi: 10.3325/cmj.2014.55.347.

Early neuropsychological detection of Alzheimer's disease

Bastin C, Salmon E.

Eur J Clin Nutr. 2014 Nov;68(11):1192-9. doi: 10.1038/ejcn.2014.176. Epub 2014 Sep 3.

CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations

Li X, Shen N, Zhang S, Liu J, Jiang Q, Liao M, Feng R, Zhang L, Wang G, Ma G, Zhou H, Chen Z, Jiang Y, Zhao B, Li K, Liu G.

Mol Neurobiol. 2015 Aug;52(1):414-21. doi: 10.1007/s12035-014-8880-9. Epub 2014 Sep 4.

Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis

Willette AA, Calhoun VD, Egan JM, Kapogiannis D; Alzheimer׳s Disease Neuroimaging Initiative.

Psychiatry Res. 2014 Nov 30;224(2):81-8. doi: 10.1016/j.pscychresns.2014.08.005. Epub 2014 Aug 17.

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S.

Alzheimers Dement. 2015 Mar;11(3):249-57.e1. doi: 10.1016/j.jalz.2014.07.001. Epub 2014 Sep 10.

3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease

Zou JX, Wang MJ, Lei XJ, Chen XG.

Exp Gerontol. 2014 Dec;60:31-6. doi: 10.1016/j.exger.2014.09.009. Epub 2014 Sep 16.

Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease

González-Domínguez R, García-Barrera T, Gómez-Ariza JL.

Anal Bioanal Chem. 2014 Nov;406(28):7137-48. doi: 10.1007/s00216-014-8102-3. Epub 2014 Sep 18.

There are no differences in IL-6, CRP and homocystein concentrations between women whose mothers had AD and women whose mothers did not have AD

Devčić S, Glamuzina L, Ruljancic N, Mihanovic M.

Psychiatry Res. 2014 Dec 30;220(3):970-4. doi: 10.1016/j.psychres.2014.08.059. Epub 2014 Sep 7.

Comparison of MR-less PiB SUVR quantification methods

Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J; AIBL Research Group.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S159-66. doi: 10.1016/j.neurobiolaging.2014.04.033. Epub 2014 Aug 27.

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, Laske C, Breteler M, Shaw L, Trojanowski JQ, Schupf N, Rissman RA, Fagan AM, Oberoi P, Umek R, Weiner MW, Grammas P, Posner H, Martins R; STAR-B and BBBIG working groups.

Alzheimers Dement. 2015 May;11(5):549-60. doi: 10.1016/j.jalz.2014.08.099. Epub 2014 Oct 1.

Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials

Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA.

Alzheimers Dement. 2015 Sep;11(9):1069-79. doi: 10.1016/j.jalz.2014.07.156. Epub 2014 Oct 7.

Volatile organic compounds (VOCs) fingerprint of Alzheimer's disease

Mazzatenta A, Pokorski M, Sartucci F, Domenici L, Di Giulio C.

Respir Physiol Neurobiol. 2015 Apr;209:81-4. doi: 10.1016/j.resp.2014.10.001. Epub 2014 Oct 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias